<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
<title>Larvol Trials</title>
<style type="text/css">
body
{
	font-family:Arial, Helvetica, sans-serif;
	font-size:14px;
	color:#000000;
}
.FoundResultsTb
{
	background-color:#aa8ece;
	border:0;
	border-top:#4f2683 solid 2px;
}
</style>
</head>

<body>
<table width="100%" border="0" style="padding-top:2px;">
	<tr>
		<td align="center">
			<a style="text-decoration:none;" href="trialzilla.php"><img src="images/larvol_sigma_logo.gif" width="300" height="50" style="border: none;" /></a>
		</td>
	</tr>
    <tr style="height:6px;">
    	<td style="border:0; font-weight:bold;" align="left">
        	
        </td>
    </tr>
    <tr>
    	<td style="font-weight:bold; padding-left:5px; padding-top:2px; padding-bottom:2px; color:#FFFFFF; font-size:28px;" align="left" class="FoundResultsTb">
        	Terms of Use
        </td>
   </tr>
   <tr>
    	<td style="border:0; padding-left:5px;" align="left">
        <br/>
		<b>Larvol Sigma</b> is a pharmaceutical intelligence platform built by The <b>Larvol Group LLC</b>. Disclaimer of warranties and limitation of liability related with this site is provided by The Larvol Group, on an “as is” and “as available” basis. TLG makes no representations or warranties of any kind, express or implied, as to the operation of this site, or the information, content or materials included on this site. By using these results, you expressly agree that your use of this site is at your sole risk. This site applies TLG’s proprietary analytic method to the information available on ClinicalTrials.gov and EudraCT; it is intended for informational purposes only. We keep the information as current and as accurate as possible.
		<br/><br/>
		If you would like information on how to use these analyses or if you have any questions or concerns, please contact The Larvol Group at <a style="display:inline;color:#0000FF;" target="_self" href="mailto:larvoltrials@larvol.com">larvoltrials@larvol.com</a>
        </td>
   </tr>
</table>

<?php include "trialzilla_footer.php" ?>

</body>
</html>
